Skip to content
Screener

Cash & Equivalents at other companies

SoundThinking, Inc. logo
SoundThinking, Inc.SSTI
$14.24M+22.2%
Arlo Technologies logo
Arlo TechnologiesARLO
$103.3M+45.0%
ADT logo
ADTADT
$151.8M+66.5%
APi Group logo
APi GroupAPG
$645M+39.9%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$115.7M-23.4%
SES AI logo
SES AISES
$46.94M-16.3%

Other financials

Income statement

See full
Revenue$46.3M+44.7%
Gross profit$23.6M+23.2%
Operating income-$8.5M+41.1%
Net income-$5.0M-197%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Total debt$42.0M+191%
Total equity$120.7M-0.3%
Total assets$304.6M+19.0%

Cash flow

See full
Operating cash flow-$3.2M-25.2%
CapEx$6.4M+107%
Free cash flow-$9.6M-70.0%

Valuation

See full
Market cap$1.07B-8.4%
Enterprise value$1.06B-7.8%
P/S6.7×-3.0×

Profitability

See full
Gross margin49.8%-8.7pp
Operating margin-26.6%-9.9pp
Net margin-43.8%-8.7pp
FCF margin6.9%

Returns & leverage

See full
Return on equity-51.7%+24.4pp
Debt / equity0.3×+0.2×
Current ratio1.2×+0.1×

Where this comes from

Reported directly by Evolv Technologies Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Evolv Technologies Holdings, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001805385-26-000028
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net increase (decrease) in cash and cash equivalents6,931(11,926)
Cash and cash equivalents
Cash and cash equivalents at beginning of period49,15037,015
Cash and cash equivalents at end of period$56,081$25,089
Supplemental disclosure of cash flow information
Cash paid for interest$446$1
Supplemental disclosure of non-cash activities
Transfer of property and equipment to inventory$656$564

Item 1. Financial Statements

FAQ

What is Evolv Technologies Holdings, Inc.'s cash & equivalents?
Evolv Technologies Holdings, Inc. (EVLV) reported cash & equivalents of $56.08M in Q1 2026.
How has Evolv Technologies Holdings, Inc.'s cash & equivalents changed year-over-year?
Evolv Technologies Holdings, Inc.'s cash & equivalents increased by 123.5% year-over-year, from $25.09M to $56.08M.
What is the long-term trend for Evolv Technologies Holdings, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Evolv Technologies Holdings, Inc.'s cash & equivalents has grown at a 59.9% compound annual growth rate (CAGR), from $4.7M to $49.15M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Evolv Technologies Holdings, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude